Evidence map›Paper›PMID 31372281›Full record

ArticleJournal of thoracic disease2019

Fractional exhaled nitric oxide was not associated with the future risk of exacerbations in Chinese asthmatics: a non-interventional 1-year real-world study.

Yafei Yuan, Bohou Li, Minyu Huang, Xianru Peng, Wenqu Zhao, Yanmei Ye, Peifang Zhang, Changhui Yu, Hangming Dong, Shaoxi Cai and 1 more

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yafei YuanDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.
Bohou LiDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.
Minyu HuangDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.
Xianru PengDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.
Wenqu ZhaoDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.
Yanmei YeDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.
Peifang ZhangDepartment of Respiratory Medicine, The First People's Hospital of Foshan, Foshan 528314, China.
Changhui YuDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.
Hangming DongDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.
Shaoxi CaiDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.
Haijin ZhaoDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Chronic Airways Diseases Laboratory, Guangzhou 510515, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExacerbations are recognized as the most relevant predictor of future risk in asthmatics. We aimed to evaluate the association between asthma exacerbations, fractional exhaled nitric oxide (FENO), spirometry indices, and other potential risk factors in a non-interventional, real-world study performed in Guangzhou, China.

methodsWe performed a prospective 12 months follow-up of Chinese asthmatics. Spirometry and FENO measurements were performed at baseline. Adherence to inhaled corticosteroids (ICS) use was divided into two categories (>80% and <80%). Patients were seen 4 times after the initial baseline visit.

resultsA total of 222 patients with asthma (49.1% males) completed the study, of which 51 (23.0%) experienced exacerbations during the study period. Of the patients, 117 (52.7%) had good compliance. We compared lung function indices between the patients with and without exacerbations. There was no difference of forced expiratory volume in 1 s (FEV1) predicted, forced vital capacity (FVC) predicted, and FEVI/FVC (all, P>0.05) between the groups. There was also no significant difference in FENO level between the two groups. Compared to those that had exacerbations, patients without exacerbations had better treatment compliance (P<0.001). Logistic regression analysis identified an association between asthma exacerbations, poor control of symptom [odds ratio (OR) =2.295; 95% confidence interval (CI): 1.130-4.663; P=0.022], and nonadherence to asthma medications (OR =4.718; 95% CI: 2.149-10.359; P<0.001).

conclusionsPoor adherence rather than baseline FENO and FEV1% predicted was associated with the future risk of exacerbations in Chinese asthmatics in real world.

Indexed as

adherenceAsthma exacerbationcontrolfractional exhaled nitric oxide (FENO)spirometry

Identifiers

PMID31372281
PMCPMC6626801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.